It’s been a pleasure to work with the talented scientists at Synecor. Their ideas and research are innovative and will potentially have a significant impact in health sciences.Robert Langer, Professor of Chemical and Biomedical Engineering, Massachusetts Institute of Technology
Synergistic Strategic Relationships
Synecor evolved from the confluence of several synergistic strategic relationships, initially in the field of interventional cardiology, but has expanded its field to include all medical specialties such as obesity, spine therapeutics, and more. Synecor was founded by Dr. Richard Stack after two decades of collaboration with leading cardiologists, clinician-inventors, and scientists from across the nation and as an outgrowth of close working relationships among corporate leaders in the medical device industry, and experts at Duke University.
We believe the following significant trends will shape the evolution of the medical device industry over the next decade.
- Major medical advances will be driven by the use of devices as platforms for the local delivery of potent biologicals and pharmaceuticals.
- The aging American population will continue to fuel ever-increasing, very large market potentials for cost-effective technologies to treat age-related and lifestyle diseases.
- Further consolidation within the medical device industry and the capricious nature of the private and public equity financial markets supporting these fledgling start-up companies will provide challenges that only the best-prepared start-up companies can successfully navigate.
To lead our start-up companies with an experienced management team and provide the strategic/technical/financial partnership support that makes Synecor the preeminent platform for medical device innovation.